Stay updated on Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new site revision label (v3.7.0) appears, replacing the previous revision (v3.6.6), indicating a platform update.
    Difference
    0.1%
    Check dated 2026-09-16T00:21:37.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.6.6' has been added. The previous revision tag 'Revision: v3.6.5' has been removed.
    Difference
    0.1%
    Check dated 2026-09-01T19:49:26.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now shown, replacing the previous v3.6.4. This change represents a new build/version of the page rather than a modification to study information.
    Difference
    0.1%
    Check dated 2026-08-11T08:33:37.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.6.3 to v3.6.4, indicating a metadata revision of the page.
    Difference
    0.1%
    Check dated 2026-07-28T05:43:43.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.3, replacing the previous v3.6.2. This indicates a minor maintenance update without changes to the study details, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2026-07-06T16:10:04.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates an update to the page's underlying revision or content, reflecting a maintenance or patch in the site's presentation rather than the clinical study details.
    Difference
    0.1%
    Check dated 2026-06-29T08:49:21.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.